iMedi.co.uk

Bob Martin Clear Wormer 100mg Film Coated Tablets For Small Dogs & Puppies

Revised: June 2014

AN: 00137/2014


SUMMARY OF PRODUCT CHARACTERISTICS


NAME OF THE VETERINARY MEDICINAL PRODUCT


Bob Martin Clear Wormer 100mg Film Coated Tablets for Small Dogs & Puppies


QUALITATIVE AND QUANTITATIVE COMPOSITION

Each tablet contains:


Active substance: mg

Nitroscanate 100


Excipients:

Titanium Dioxide (E171) 0.778

Iron Oxide Yellow (E172) 0.0257

Iron Oxide Black (E172) 0.00003

Iron Oxide Red (E172) 0.00003


For the full list of excipients, see section 6.1


PHARMACEUTICAL FORM


Film-Coated Tablet.

Smooth yellow coloured film coated tablets, convex shaped (plain round concave)


CLINICAL PARTICULARS


Target species


Dog.


Indications for use, specifying the target species


The tablets should be given whole and not broken or divided. For the routine control of Toxocara canis, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma canium, Taenia hydatigena, Taenia pisiformisand Dipylidium caninum. The product gives a limited level of control of Echinococcus granulosusand is not indicated for the treatmentof Trichuris vulpis.


Contraindications


When administered as recommended, the product is unlikely to cause vomiting. However, if vomiting does occur after treatment, do not repeat the dose. If a hypersensitive reaction occurs, treatment with the product should be discontinued. Do not administer to sick or convalescing animals. Do not administer to puppies weighing less than 0.5kg (1.1lb).


Special warnings for each target species


It is recommended that adult dogs should be wormed routinely 2-4 times a year. Since the most common tapeworm of the dog (Dipylidium caninum)is transmitted by a flea and has a very short pre-patent period it is important to pay attention to flea control to reduce the incidence of tapeworm in your pet.


In the unlikely event of a pup vomiting repeatedly, following the use of this product, seek advice of a veterinary surgeon. Do not repeat treatment if vomiting occurs shortly after dosing.


Special precautions for use


Special precautions for use in animals


Do not administer to puppies weighing less than 0.5kg (1.1lb)

Nursing bitches should be treated at the same time as their puppies until weaning.


Special precautions to be taken by the person administering the veterinary medicinal product to animals


This product can be an irritant to the skin and eyes. Tablets are film-coated and should not be broken or divided


Adverse reactions (frequency and seriousness)


When administered as recommended, the product is unlikely to cause vomiting. Do not repeat treatment if vomiting occurs shortly after dosing.


Use during pregnancy, lactation or lay


Nursing bitches should be treated at the same time as their puppies until weaning.


Interaction with other medicinal products and other forms of interaction


None known.


Amounts to be administered and administration route


Dose: For routine control of roundworm and tapeworm in small dogs and puppies give 1 x 100mg tablet per 2kg (4.4lb) bodyweight, equivalent to 50mg nitroscanate/kg bodyweight.


For dogs weighing more than 8kg (17.5lb) use Bob Martin Clear Wormer 500mg Film Coated Tablets for Dogs. For puppies weighing less than 0.5kg (1.1lb) seek veterinary advice.


Directions for use: Give the required number of tablets first thing in the morning when your dog's stomach is empty with about one fifth of his daily food ration.


Give your dog his remaining food in the evening at least eight hours after the wormer dose.


Treat unweaned puppies first thing in the morning and restrict their suckling for 2-4 hours after dosing at which time they may be returned to the bitch.


When dosing recently weaned puppies (6-8 weeks of age) ensure fresh drinking water is readily available.


It is advisable to treat young puppies regularly for roundworm. Treat at two weeks old and every following two weeks until eight weeks of age. Then treat again at 12, 16 and 24 weeks of age. Thereafter, every 3-6 months is recommended. Nursing bitches should be treated at the same time as their puppies until they are weaned.


It is recommended to worm adult dogs every 3-6 months as a routine measure.


Overdose (symptoms, emergency procedures, antidotes), if necessary


No treatment specified.


Withdrawal period


Not applicable.


PHARMACOLOGICAL IMMUNOLOGICAL PROPERTIES


Active Substance:Nitroscanate

Pharmacotherapeutic group: Anthelmintic.

ATCVet Code: QP52AX01


Pharmacodynamic properties


Nitroscanate is an isothiocyanate anthelmintic with established use in veterinary practice. It is effective against common gastrointestinal cestodes and nematodes.


Pharmacokinetic particulars


None known.


PHARMACEUTICAL PARTICULARS


List of excipients


Titanium Dioxide (E171)

Iron Oxide Yellow (E172)

Iron Oxide Black (E172)

Iron Oxide Red (E172)

Maize starch

Sodium starch glycolate (Type A)

Microcrystalline cellulose

Sodium laurel sulphate

Magnesium stearate

HPMC 2910

Polydextrose FCC

Macrogoll 4000


Incompatibilities


Not applicable.


Shelf life


Shelf life of the veterinary medicinal product as packaged for sale: 5 years.


Special precautions for storage


Store in a dry place. Do not store above 25°C. Keep blister strip in outer carton.


Nature and composition of immediate packaging


Aluminium foil strips, low density polyethylene strip packs with heat sealed closure containing 4 x 100mg or 6 x 100mg tablets.


Carton containing 4 or 6 tablets


Not all pack sizes will be marketed.


Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


MARKETING AUTHORISATION HOLDER


Chanelle Animal Health Ltd.

7 Rodney St.

Liverpool

L1 9HZ


MARKETING AUTHORISATION NUMBER


Vm:11990/4029


DATE OF FIRST AUTHORISATION


Date:16 April 2002


DATE OF REVISION OF THE TEXT


Date:June 2014


26 June 2014